1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Extrapulmonary Small Cell Carcinoma: new trials by email Literature Review of Extrapulmonary Small Cell Carcinoma trials Research Report on Extrapulmonary Small Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AGNOSTIC THERAPY IN A PHASE II SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB IN ASSOCIATION WITH CARBOPLATIN OR CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY EXTENSIVE STAGE - EXTRAPULMONARY SMALL CELL CARCINOMA Durvalumab - Extrapulmonary Small Cell Carcinoma | Phase 2 | Recruiting | Gruppo Oncologico Italiano di Ricerca Clinica | 66 | 2024-01-16 | 2024-06-18 |
| Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC Abemaciclib, - Small-cell Lung Cancer, Large Cell Neuroendocrine Carcinoma of the Lung | Phase 2 | Completed | Case Comprehensive Cancer Center | 14 | 2020-01-13 | 2026-05-12 |
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Etoposide (1) · abemaciclib (1) · durvalumab (1)
Case Comprehensive Cancer Center (1) · Gruppo Oncologico Italiano di Ricerca Clinica (1)
Italy (1) · United States (1)
Afshin Dowlati, MD (1) · Angela Damato, MD (1)